Zusammenfassung
Zum Zeitpunkt der Diagnose befinden sich 80–90% aller Patientinnen mit Brustkrebs in einem operablen und 10–20% der Patientinnen in einem lokal fortgeschrittenen, inoperablen oder metastasierten Stadium.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Howe JR, Monsees B, Destouet J, Seib J, Dehner LP, Kraybil WG (1995) Needle localization breast biopsy: A model for multi-disciplinary quality assurance. J Surg Oncol 58: 233–239
Morrow M (1995) When can stereotactic core biopsy replace excisional biopsy? A clinical perspective. Breast Cancer Res Treat 36:1–9
Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohi-stochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–40
Veronesi U, Volterani F, Luini A et al. (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Europ J Cancer 26: 671
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kreienberg, R., Volm, T., Beck, T. (2002). Präoperative Diagnostik. In: Kreienberg, R., Volm, T., Möbus, V., Alt, D. (eds) Management des MAMMAKARZINOMS. Onkologie Aktuell . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08460-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-08460-1_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-08461-8
Online ISBN: 978-3-662-08460-1
eBook Packages: Springer Book Archive